Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Other Working Capital Changes of -$2.1 million for Q1 2026, down 38.11% year-over-year from -$3.3 million in Q1 2025, and up 25.0% quarter-over-quarter from -$2.8 million in Q4 2025.
Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Revolution Medicines' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 38.11% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$1.5 million (up 16.49% YoY), while the FY2025 annual figure was -$957000.0, down 290.61% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$2.1 million, up from -$2.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $10.5 million in Q1 2026, with the low at -$6.4 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $2.3 million (2023), against an average of $2.1 million.
- Peak annual rise in Other Working Capital Changes reached 1277.02% in 2025, while the deepest fall reached 1865.88% in 2025.
- Revolution Medicines' Other Working Capital Changes stood at -$2.4 million in 2022, then sank by 143.02% to -$5.9 million in 2023, then jumped by 79.07% to -$1.2 million in 2024, then sank by 125.63% to -$2.8 million in 2025, then climbed by 25.0% to -$2.1 million in 2026.
- Business Quant data shows RVMD's Other Working Capital Changes at -$2.1 million in Q1 2026, -$2.8 million in Q4 2025, and -$4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.87 Mn |
| Jun 30, 2026 | -9.87 Mn |
| Jun 30, 2026 | -9.87 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | -3.97 Mn |
| Sep 30, 2025 | -3.97 Mn |
| Sep 30, 2025 | -3.97 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Dec 31, 2024 | -1.23 Mn |